In cellular PD models, PHD inhibitors normalize the mitochondrial membrane potential and the rate of mitochondrial oxygen consumption, and reduce the production of reactive oxygen species (Zhang et al., 2018). The gene discussed is PDC; the disease is Parkinson disease.